These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1708047)
1. Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive rats. Barrett RJ; Wright KF; Allen AD; Taylor DR J Cardiovasc Pharmacol; 1991 Jan; 17(1):134-44. PubMed ID: 1708047 [TBL] [Abstract][Full Text] [Related]
2. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels. Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055 [TBL] [Abstract][Full Text] [Related]
3. Azelnidipine attenuates cardiovascular and sympathetic responses to air-jet stress in genetically hypertensive rats. Nakamoto M; Ohya Y; Sakima A; Yamazato M; Takishita S Hypertens Res; 2007 Apr; 30(4):359-66. PubMed ID: 17541215 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil. Hefti F; Clozel JP; Osterrieder W Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242 [TBL] [Abstract][Full Text] [Related]
6. Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat. Gradin K; Pettersson A; Hedner T; Persson B J Neural Transm; 1985; 64(2):145-9. PubMed ID: 2934513 [TBL] [Abstract][Full Text] [Related]
7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
8. Sympathoinhibitory effects of central nifedipine in spontaneously hypertensive rats on high versus regular sodium intake. Huang BS; Leenen FH Hypertension; 1999 Jan; 33(1):32-5. PubMed ID: 9931078 [TBL] [Abstract][Full Text] [Related]
9. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541 [TBL] [Abstract][Full Text] [Related]
10. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat. Smits J; van Dorsten F; Struyker Boudier H Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats. Petty MA; Mir AK Br J Pharmacol; 1988 Aug; 94(4):1218-24. PubMed ID: 3207982 [TBL] [Abstract][Full Text] [Related]
12. Vascular and cardiac effects of DV-7028, a selective, 5-HT2-receptor antagonist in rats. Pawlak D; Adamkiewicz M; Malyszko J; Takada A; Mysliwiec M; Buczko W J Cardiovasc Pharmacol; 1998 Aug; 32(2):266-73. PubMed ID: 9700989 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats. Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular pharmacology of nicardipine in animals. Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153 [TBL] [Abstract][Full Text] [Related]
15. Effects of CS-905, a novel dihydropyridine calcium channel blocker, on arterial pressure, renal excretory function, and inner medullary blood flow in the rat. Yagil Y; Miyamoto M; Frasier L; Oizumi K; Koike H Am J Hypertens; 1994 Jul; 7(7 Pt 1):637-46. PubMed ID: 7946166 [TBL] [Abstract][Full Text] [Related]
16. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond. Kirchengast M J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A; Kubo K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B; Gradin K; Pettersson A; Hedner T J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats. Nomura M; Kimura Y; Yoshida M; Satoh S Arzneimittelforschung; 1989 Dec; 39(12):1542-5. PubMed ID: 2624602 [TBL] [Abstract][Full Text] [Related]
20. Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats. Fenoy FJ; Milicic I; Mistry M; Mecca TE; Roman RJ J Pharmacol Exp Ther; 1992 May; 261(2):470-5. PubMed ID: 1578362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]